Drug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities
Growth is driven by the aging population, rising chronic diseases, and self-administration practices. Advances in technology, new product launches, and favorable policies bolster growth. Injectable drug delivery devices, particularly autoinjectors, lead the market, thanks to user-centric designs improving patient adherence. North America holds the largest share, fueled by a notable chronic disease presence, while the Asia Pacific is poised for the fastest growth. Major players include Abbott, Medtronic, and Novartis. Explore insights on market trends, key drivers, and growth strategies in the comprehensive market report.
Drug Device Combination Products Market
Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.The global drug device combination products market is projected to reach USD 379.17 billion by 2030 from USD 243.02 billion in 2025, at a CAGR of 9.3% during the forecast period. The rapid expansion of the geriatric demographic, coupled with a notable increase in patients suffering from chronic conditions such as diabetes and cardiovascular diseases, is projected to drive the market for drug-device combination products significantly. Additionally, the steady rise in self-administration practices and a heightened emphasis on patient-centric design and adherence to treatment regimens are expected to further propel market growth.
Technological advancements in drug-device combination products, the introduction of innovative products, and favorable reimbursement frameworks, along with supportive government policies, are all anticipated to enhance market dynamics. Furthermore, strategic investments in healthcare infrastructure and initiatives to improve the accessibility and affordability of these combination products will likely contribute significantly to market expansion.
Currently, North America dominates this market due to its substantial burden of chronic diseases, particularly diabetes, which enlarges the patient demographic that relies on these combination products. The region's market growth is further bolstered by the presence of several major industry players and supportive reimbursement policies that facilitate access to innovative therapies. Meanwhile, the Asia Pacific region is projected to experience the highest CAGR during the forecast period, indicating a burgeoning demand and potential for expansion in this sector.
The major players operating in the drug device combination products market are Abbott (US), Boston Scientific Corporation (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), AbbVie Inc. (US), Teva Pharmaceutical Industries Ltd. (Israel), Stryker (US), B. Braun SE (Germany), Terumo Corporation (Japan) and Kaleo, Inc.(US).The injectable drug delivery devices segment is expected to grow at the highest CAGR during the forecast period.In the realm of drug-device combination products, injectable drug delivery systems command the largest market share and are experiencing accelerated growth. This trend is predominantly due to their capacity for rapid, targeted administration of complex biologics and other therapies that are unsuitable for oral delivery routes. The escalating prevalence of chronic diseases, such as diabetes and cancer, is a primary driver of demand in this sector. Additionally, the industry is witnessing a paradigm shift towards self-administration facilitated by user-centered designs, including autoinjectors and pen injectors. Continuous innovation in device technology is enhancing patient comfort, safety, and adherence, further propelling market growth.The autoinjectors subsegment of the injectable drug delivery devices segment captured the largest market share in 2024.The injectable drug delivery devices can be subcategorized into prefilled syringes, pen injectors, autoinjectors, needle-free injectors, and wearable injectors. Among these, autoinjectors have experienced a pronounced growth trajectory in the market due to their user-friendly design, convenience, and capability to administer accurate doses of medication.
These features make autoinjectors particularly suitable for patients with chronic conditions such as diabetes and multiple sclerosis. The architecture of autoinjectors facilitates self-administration, which enhances patient adherence to treatment regimens and minimizes the necessity for frequent visits to healthcare facilities. Given the rising emphasis on home-based care and patient-centric therapeutic solutions, the market for autoinjectors is poised for significant expansion.Key Attributes:
Report Attribute
Details
No. of Pages
346
Forecast Period
2025 - 2030
Estimated Market Value (USD) in 2025
$243.02 Billion
Forecasted Market Value (USD) by 2030
$379.17 Billion
Compound Annual Growth Rate
9.3%
Regions Covered
Global
Market Dynamics
Drivers
Rising Prevalence of Chronic Diseases
Growing Adoption of Biologics and Vaccines
High R&D Investments from Government Organizations and Private Bodies
Shift Toward Personalized Medicines and Patient-Centric Care
Rising Popularity of Self-Administered Medicines
Restraints
Stringent Regulatory Policies and Compliance Hurdles
Focus on Alternative Drug Delivery Methods
Opportunities
Increased Preference for Minimally Invasive Products
High Growth Potential in Emerging Economies
Growing Adoption of Drug Device Combination Products and Expanding Biologics Market
Challenges
Heavy Financial Impact of Drug Wastage and Device Malfunction
Lack of Standardized Reimbursement Policies
Limited Training and Education for Healthcare Professionals
Lack of Medical Specialists and Surgeons
Industry Trends
Rising Popularity of Self-Administered Medicines and Home Care Settings
Integration of Drug Device Combination Products with Smart Connected Devices
Technology Analysis
Key Technologies
Wearable Technologies
Drug-Eluting Technologies
Complementary Technologies
Connected Health and Digital Technologies
Adjacent Technologies
Advanced Materials and Biopolymers
Case Study Analysis
Minimed 780G Diabetes Management System to Combine Continuous Glucose Monitoring with Automated Insulin Delivery
Digiinhaler-Smart Inhaler for Asthma/Copd to Track Lung Function
Adoption of Pen Injectors by Nemera France to Improve Therapeutic Outcomes
Business Impacts
Supply Chain Analysis
Trends/Disruptions Impacting Customers' Businesses
Investment & Funding Scenario
Reimbursement Scenario Analysis
Clinical Pipeline Analysis
Impact of AI/Gen AI on Drug Device Combination Products Market
Impact of 2025 US Tariff on Drug Device Combination Products Market
Companies Featured
Key Players
Abbott
Eli Lilly and Company
Medtronic
Novo Nordisk A/S
Novartis AG
Sanofi
Boston Scientific Corporation
Becton, Dickinson and Company
Merck KGaA
AbbVie Inc.
Teva Pharmaceutical Industries Ltd.
Stryker
B. Braun SE
Terumo Corporation
Other Players
Tandem Diabetes Care, Inc.
Cequr Simplicity
Intarcia Therapeutics, Inc.
Halozyme, Inc.
Kaleo, Inc.
Lead Chemical Co. Ltd.
Purdue Pharma L.P.
Alvogen
Evolutis
Mundipharma International Limited
Sparsha Pharma International Pvt. Ltd.
Supernus Pharmaceuticals, Inc.
Alcon Inc.
For more information about this report visit https://www.researchandmarkets.com/r/sw8yf2
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Drug Device Combination Products Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Analyzing Regional Dynamics and Policy Shifts in Aircraft Propulsion Systems Market
Significant market opportunities in the electric and hybrid aircraft propulsion sector include advancements in battery energy density, public and regulatory pressure for sustainability, and rising demand for urban air mobility. Collaborative R&D and domestic manufacturing expansions in response to tariff impacts are key to capitalizing on these opportunities. Electric & Hybrid Aircraft Propulsion System Market Dublin, June 02, 2025 (GLOBE NEWSWIRE) -- The "Electric & Hybrid Aircraft Propulsion System Market by Aircraft Type, Propulsion Type, Component, Power Output, End Use - Global Forecast to 2030" has been added to offering. The Electric & Hybrid Aircraft Propulsion System Market is undergoing a significant transformation, reflecting the aviation industry's commitment to sustainable propulsion technologies. This research report explores the rapid growth trajectory, with the market expected to expand from USD 2.45 billion in 2024 to USD 9.32 billion by 2030. By leveraging innovative propulsion systems, industry players aim to significantly reduce carbon emissions and improve energy efficiency - a vital step in addressing environmental regulations and achieving sustainability goals. Navigating the Dawn of Electric and Hybrid Aircraft Propulsion Aviation stakeholders - ranging from OEMs to airlines - are reassessing propulsion strategies as legacy turbine engines transition to integrated electric motor systems. Enhancements in battery energy density, power electronics, and electric motor technologies are driving this shift. The introduction of turboelectric and hybrid configurations provides flexible design options, allowing for a blend of traditional and new powertrain technologies. Pivotal Technological and Regulatory Shifts Technological advancements, coupled with stricter environmental regulations, are significant propellants of propulsion innovation. Governments worldwide have implemented emissions targets and financial incentives to encourage the development of low-carbon aviation solutions. The increasing importance of urban air mobility and regional short-haul networks necessitates scalable propulsion solutions, prompting collaboration across sectors to reduce costs and boost reliability. Deciphering Market Segmentation Market segmentation reveals diverse adoption trajectories for electric and hybrid systems across various aircraft types. Business aviation is exploring short-range electric platforms, while commercial segments focus on hybrid retrofits for narrow-body fleets. Military applications are also considering hybrid configurations for aircraft, pioneering new energy storage solutions. By understanding this segmentation, decision-makers can identify specific opportunities for strategic planning and market entry. Regional Landscape Influencing Adoption Trends Regional dynamics play a critical role in shaping propulsion system adoption. The Americas lead with substantial government funding and an extensive aerospace base, while Europe and Africa are driven by ambitious sustainability agendas. Asia-Pacific is emerging as a pivotal growth engine, with countries like China and Japan investing heavily in indigenous propulsion development, further enriched by collaborative efforts with global technology leaders. Competitive Dynamics and Leading Innovators Dominant players such as Airbus, Boeing, Rolls-Royce, and GE Aviation are advancing propulsion platforms through large-scale research initiatives. New entrants like ZeroAvia and Heart Aerospace are leveraging strategic alliances to expedite prototype testing and demonstrate regional flights with hybrid systems. These dynamics offer a competitive advantage to decision-makers who can identify opportunities to collaborate and gain a competitive edge. Strategic Recommendations Prioritize cross-sector partnerships to leverage advances in battery chemistry and power electronics. Optimize supply chains with near-shoring models to manage trade-related cost pressures. Focus initial deployments on hybrid retrofits before scaling to full electric solutions. Embed sustainability metrics in program roadmaps to enhance market positioning and meet evolving environmental criteria. Assessing the 2025 Tariff Regime The US tariffs imposed in 2025 have introduced challenges but also opportunities, such as encouraging investment in local manufacturing and promoting domestic supply chains. By navigating these changes, companies can enhance operational resilience, optimize sourcing strategies, and achieve competitive advantages in regional markets. Key Takeaways from This Report Hybrid propulsion systems will dominate near-term market deployments, while full electric solutions will evolve in niche applications. Regional propulsion leadership depends on regulatory harmonization and infrastructure investment. Strategic collaboration and adaptive supply chain models are critical for competitive positioning. Sustainability commitments key to long-term growth and market differentiation. Synthesizing Insights for Strategic Planning This comprehensive analysis integrates technological, regional, and competitive insights, empowering aerospace stakeholders to craft robust strategies that balance risk with opportunity. Investing in integrated propulsion technologies and supply chain agility is essential for proactively addressing future challenges and capitalizing on emerging growth prospects. Key Attributes: Report Attribute Details No. of Pages 197 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $3.09 Billion Forecasted Market Value (USD) by 2030 $9.32 Billion Compound Annual Growth Rate 24.8% Regions Covered Global Key Topics Covered: 1. Preface2. Research Methodology3. Executive Summary4. Market Overview4.1. Introduction4.2. Market Sizing & Forecasting5. Market Dynamics6. Market Insights6.1. Porter's Five Forces Analysis6.2. PESTLE Analysis7. Cumulative Impact of United States Tariffs 20258. Electric & Hybrid Aircraft Propulsion System Market, by Aircraft Type8.1. Introduction8.2. Business Aviation8.3. Commercial Aviation8.3.1. Narrow Body8.3.2. Regional Jet8.3.3. Wide Body8.4. General Aviation8.5. Military Aviation8.5.1. Fighter Aircraft8.5.2. Helicopter8.5.3. Patrol Aircraft8.5.4. Transport Aircraft8.6. Regional Aviation8.7. Urban Air Mobility9. Electric & Hybrid Aircraft Propulsion System Market, by Propulsion Type9.1. Introduction9.2. Full Electric9.3. Hybrid Electric9.3.1. Parallel Hybrid9.3.2. Series Hybrid9.3.3. Series-Parallel Hybrid9.4. Turboelectric10. Electric & Hybrid Aircraft Propulsion System Market, by Component10.1. Introduction10.2. Battery10.2.1. Flow Battery10.2.2. Lithium Ion10.2.3. Solid State10.3. Generator10.4. Motor10.4.1. AC Motor10.4.2. DC Motor10.5. Power Electronics10.6. Transmission11. Electric & Hybrid Aircraft Propulsion System Market, by Power Output11.1. Introduction11.2. 1 to 5 MW11.3. Above 5 MW11.4. Under 1 MW12. Electric & Hybrid Aircraft Propulsion System Market, by End Use12.1. Introduction12.2. New Aircraft12.3. Retrofit12.3.1. Electric Kits12.3.2. Hybrid Kits13. Americas Electric & Hybrid Aircraft Propulsion System Market14. Europe, Middle East & Africa Electric & Hybrid Aircraft Propulsion System Market15. Asia-Pacific Electric & Hybrid Aircraft Propulsion System Market16. Competitive Landscape16.1. Market Share Analysis, 202416.2. FPNV Positioning Matrix, 202416.3. Competitive Analysis Rolls-Royce General Electric Company Pratt & Whitney Inc. Safran SA Honeywell International Inc. Siemens AG Thales S.A. MTU Aero Engines AG Collins Aerospace Inc. magniX Pty Ltd For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Electric & Hybrid Aircraft Propulsion System Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
2 hours ago
- Business Upturn
Spark Capital PWM Establishes Strategic Presence in Dubai International Financial Centre to Serve Global Investors
By Business Wire Published on June 2, 2025, 11:30 IST Mumbai, Maharashtra, India: Spark Capital Private Wealth Management (Spark Capital PWM), today announced the launch of its operations in Dubai International Financial Centre (DIFC), the leading global financial centre in the Middle East, Africa and South Asia (MEASA) region through Spark Global PWM Private Limited. Spark Global PWM Private Limited, a CAT4 firm regulated by Dubai Financial Services Authority, the independent regulator for business conducted from or within Dubai International Financial Centre (DIFC), operates as a subsidiary of Spark Capital's Private Wealth Management business and the new office will serve as a hub for its Middle East operations. This strategic expansion will enable global investors to access diverse markets with ease while offering its clients comprehensive portfolio diversification opportunities. The move reinforces Spark Capital's commitment to delivering sophisticated, bespoke wealth management solutions on an international scale. Spark Capital PWM has significantly focused on growth & expansion in recent years. Its AUM & AUA has grown nearly 10x—from INR ~3,000 crores (~360.24 million USD) in April 2023 to INR ~30,000 crores (~3.56 billion USD) in May 2025. The firm has also scaled its team from 60 to over 400 professionals, including 130+ seasoned relationship managers, and established a pan-India presence across 12 cities. Commenting on the expansion, Arpita Vinay, Senior Managing Director & Co-CEO, Spark Capital Private Wealth Management Private Limited, said, 'The establishment of our DIFC office represents a significant milestone in Spark Capital PWM's global growth strategy. Dubai's strategic location and robust financial infrastructure provide an ideal platform to connect investors across regions with diverse investment opportunities. This expansion allows us to enhance our service offerings to international clients while creating new avenues for wealth creation and preservation.' Neeraj Ojha, Senior Executive Officer, Spark Global PWM Private Limited, added, 'DIFC offers an exceptional ecosystem for wealth management firms, with its world-class regulatory framework and access to a wide network of financial institutions. Through our presence here, we aim to provide professional clients in the Middle East with comprehensive wealth solutions backed by Spark Capital's expertise and innovation in investment management.' DIFC is a strategic gateway to financial institutions and multinational firms in the region. DIFC continues to experience exponential growth in the wealth and asset management sector with 420 wealth and asset management firms and over 75 pure play hedge funds, 48 of which are 'billion-dollar club' organisations, that are capitalising on regional opportunities. Spark Global PWM Private Limited's DIFC office will be staffed by a team of experienced wealth management professionals with extensive knowledge of global markets and a proven track record of delivering exceptional client outcomes. These professionals will leverage the firm's comprehensive research capabilities, innovative investment strategies, and established track record in wealth management to provide tailored solutions to clients in the region. This approach underscores Spark Capital's dedication to client-centric service while strengthening its position as a trusted wealth management partner globally. About Spark Capital Private Wealth Management Spark PWM Pvt Ltd, operates as a subsidiary of Spark Capital Advisors (India) Limited. Aligning with Spark Capital's core values of Knowledge, Integrity, Trust & Transparency, Spark PWM endeavours to assist Affluent Families, Business Owners / Promoters, Family Offices, New Age Entrepreneurs, and CXOs in navigating the complexities of the financial landscape. The company's mission is to seamlessly facilitate the creation, preservation, and transition of wealth across generations through its range of products and services. As part of Spark Capital's ecosystem, Spark Capital PWM extends its offerings beyond traditional wealth management services to include investment banking and asset management expertise. This integrated approach enables Spark Capital PWM to tailor bespoke solutions to meet the diverse needs of its clientele. About Dubai International Financial Centre Dubai International Financial Centre (DIFC) is one of the world's most advanced financial centres, and the leading financial hub for the Middle East, Africa, and South Asia (MEASA), which comprises 77 countries with an approximate population of 3.7bn and an estimated GDP of USD 10.5trn. With a 20-year track record of facilitating trade and investment flows across the MEASA region, the Centre connects these fast-growing markets with the economies of Asia, Europe, and the Americas through Dubai. DIFC is home to an internationally recognised, independent regulator and a proven judicial system with an English common law framework, as well as the region's largest financial ecosystem of 46,000 professionals working across over 6,900 active registered companies – making up the largest and most diverse pool of industry talent in the region. The Centre's vision is to drive the future of finance through cutting-edge technology, innovation, and partnerships. Today, it is the global future of finance and innovation hub offering one of the region's most comprehensive AI, FinTech and venture capital environments, including cost-effective licensing solutions, fit-for-purpose regulation, innovative accelerator programmes, and funding for growth-stage start-ups. Comprising a variety of world-renowned retail and dining venues, a dynamic art and culture scene, residential apartments, hotels, and public spaces, DIFC continues to be one of Dubai's most sought-after business and lifestyle destinations. Click here for Media Contact Details Aashish Mudbidri (Group Head- Branding & Corporate Communications), Spark Capital Advisors Pvt. Ltd., [email protected] Rasha Mezher (Manager, Marketing & Corporate Communications), Dubai International Financial Centre Authority, [email protected] , +9714 3622451 Submit your press release Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same. Business Wire is an American company that disseminates full-text press releases from thousands of companies and organizations worldwide to news media, financial markets, disclosure systems, investors, information web sites, databases, bloggers, social networks and other audiences.
Yahoo
3 hours ago
- Yahoo
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
FRANKFURT (Reuters) -Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate cancer, raising the prospect of treatment in an earlier disease stage for a drug technology that the drugmaker has pioneered. The Swiss drugmaker reported a late-stage trial showed a "clinically meaningful benefit" in progression-free survival with a positive trend in overall survival in patients with metastatic prostate cancer that still responds to standard hormone therapy. Almost all of those patients ultimately progress to a form of cancer that no longer responds to hormone therapy, a setting where Pluvicto is already approved, the company added. "These data suggest using (Pluvicto) in an earlier disease setting," Novartis said, adding that this could address a significant unmet need. Novartis only provided a brief summary of trial results and said details would be presented at a medical conference and that it would likely request regulatory approval for wider use in the second half of the year. Pluvicto is part of a class of drugs that combines cell-killing radioactive particles with molecules that attach themselves to tumours, where Novartis has a leading position. The drug saw first-quarter revenue gain 20% to $371 million. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
